Nvidia, Eli Lilly, Bristol-Myers Squibb, and Hoffmann-La Roche announced a partnership to build a hybrid-cloud AI factory and powerful AI infrastructure.

The entities involved

• Nvidia →

  American multinational technology company

  • Apple is utilizing TSMC for advanced chip manufacturing, a trend observed alongside market pricing pressures affecting sales volume.Mon 17:45
  • A market sell-off hit major chip companies (AMD, Intel, Micron, Samsung, Nvidia) as the AI trade cooled and investors entered risk-off mode.Mon 17:34
• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• Bristol-Myers Squibb →

  American pharmaceutical company

  • Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
  • FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
• Hoffmann-La Roche →

  Swiss healthcare company

  • Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
  • Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08

Related events

• Control Data Corporation and IREN are partnering with Nvidia to build AI computing infrastructure in Australia.Sep 11
• Amazon and Nvidia deepened their strategic collaboration on AI stack expansion, adopting NVIDIA platforms for physical AI workloads.Aug 26
• Cisco, Nvidia, and Supermicro announced a partnership to establish a Secure AI Factory leveraging rack-scale AI servers.Aug 27
• Nvidia, IonQ, AstraZeneca, and AWS are partnering to demonstrate advanced computing workflows using a standard CPU.Wed 14:13
• Nvidia, Bloom Energy, and Micron Technology are involved in the AI process alongside other companies.Sep 11